Single-cell heterogeneity in ductal carcinoma in situ of breast.
Heterogeneous patterns of mutations and RNA expression have been well documented in invasive cancers. However, technological challenges have limited the ability to study heterogeneity of protein expression. This is particularly true for pre-invasive lesions such as ductal carcinoma in situ of the br...
Main Authors: | Gerdes, M, Gökmen-Polar, Y, Sui, Y, Pang, A, LaPlante, N, Harris, A, Tan, P, Ginty, F, Badve, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Nature Publishing Group
2017
|
Similar Items
-
Is conservative management of ductal carcinoma in situ risky?
by: Lan Zheng, et al.
Published: (2022-04-01) -
Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
by: Sunil S. Badve, et al.
Published: (2022-08-01) -
Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model
by: Soumya Ghose, et al.
Published: (2023-03-01) -
Expression score (Escore) for the prediction of likelihood of recurrence of DCIS
by: Badve, SS, et al.
Published: (2019) -
Ductal carcinoma in situ of the breast
by: Jennifer L. Peterson, et al.
Published: (2011-12-01)